Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40


A Study of In vitro Antifungal Susceptibility Patterns of Dermatophytic Fungi at a Tertiary Care Center in Western India.

Poojary S, Miskeen A, Bagadia J, Jaiswal S, Uppuluri P.

Indian J Dermatol. 2019 Jul-Aug;64(4):277-284. doi: 10.4103/ijd.IJD_456_18.


The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection.

Singh S, Uppuluri P, Mamouei Z, Alqarihi A, Elhassan H, French S, Lockhart SR, Chiller T, Edwards JE Jr, Ibrahim AS.

PLoS Pathog. 2019 Aug 5;15(8):e1007460. doi: 10.1371/journal.ppat.1007460. eCollection 2019 Aug.


Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis.

Gebremariam T, Alkhazraji S, Soliman SSM, Gu Y, Jeon HH, Zhang L, French SW, Stevens DA, Edwards JE Jr, Filler SG, Uppuluri P, Ibrahim AS.

Sci Adv. 2019 Jun 12;5(6):eaaw1327. doi: 10.1126/sciadv.aaw1327. eCollection 2019 Jun.


Candida albicans biofilm growth and dispersal: contributions to pathogenesis.

Wall G, Montelongo-Jauregui D, Vidal Bonifacio B, Lopez-Ribot JL, Uppuluri P.

Curr Opin Microbiol. 2019 Dec;52:1-6. doi: 10.1016/j.mib.2019.04.001. Epub 2019 May 11. Review.


NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice.

Alqarihi A, Singh S, Edwards JE Jr, Ibrahim AS, Uppuluri P.

Sci Rep. 2019 Apr 17;9(1):6194. doi: 10.1038/s41598-019-42517-y.


Metabolic Profiling of Candida auris, a Newly-Emerging Multi-Drug Resistant Candida Species, by GC-MS.

Semreen MH, Soliman SSM, Saeed BQ, Alqarihi A, Uppuluri P, Ibrahim AS.

Molecules. 2019 Jan 22;24(3). pii: E399. doi: 10.3390/molecules24030399.


Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.

Mamouei Z, Alqarihi A, Singh S, Xu S, Mansour MK, Ibrahim AS, Uppuluri P.

mSphere. 2018 Oct 31;3(5). pii: e00539-18. doi: 10.1128/mSphere.00539-18.


Candida albicans Dispersed Cells Are Developmentally Distinct from Biofilm and Planktonic Cells.

Uppuluri P, Acosta Zaldívar M, Anderson MZ, Dunn MJ, Berman J, Lopez Ribot JL, Köhler JR.

mBio. 2018 Aug 21;9(4). pii: e01338-18. doi: 10.1128/mBio.01338-18.


Intersection of phosphate transport, oxidative stress and TOR signalling in Candida albicans virulence.

Liu NN, Uppuluri P, Broggi A, Besold A, Ryman K, Kambara H, Solis N, Lorenz V, Qi W, Acosta-Zaldívar M, Emami SN, Bao B, An D, Bonilla FA, Sola-Visner M, Filler SG, Luo HR, Engström Y, Ljungdahl PO, Culotta VC, Zanoni I, Lopez-Ribot JL, Köhler JR.

PLoS Pathog. 2018 Jul 30;14(7):e1007076. doi: 10.1371/journal.ppat.1007076. eCollection 2018 Jul.


Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis.

Uppuluri P, Singh S, Alqarihi A, Schmidt CS, Hennessey JP Jr, Yeaman MR, Filler SG, Edwards JE, Ibrahim AS.

Front Immunol. 2018 Jun 15;9:1349. doi: 10.3389/fimmu.2018.01349. eCollection 2018.


The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.

Uppuluri P, Lin L, Alqarihi A, Luo G, Youssef EG, Alkhazraji S, Yount NY, Ibrahim BA, Bolaris MA, Edwards JE Jr, Swidergall M, Filler SG, Yeaman MR, Ibrahim AS.

PLoS Pathog. 2018 May 10;14(5):e1007056. doi: 10.1371/journal.ppat.1007056. eCollection 2018 May.


Transcriptional Profiling of C. albicans in a Two Species Biofilm with Rothia dentocariosa.

Uppuluri P, Busscher HJ, Chakladar J, van der Mei HC, Chaffin WL.

Front Cell Infect Microbiol. 2017 Jul 13;7:311. doi: 10.3389/fcimb.2017.00311. eCollection 2017.


Assessment of herbal drugs for promising anti-Candida activity.

Soliman SSM, Semreen MH, El-Keblawy AA, Abdullah A, Uppuluri P, Ibrahim AS.

BMC Complement Altern Med. 2017 May 8;17(1):257. doi: 10.1186/s12906-017-1760-x.


Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.

Gebremariam T, Wiederhold NP, Alqarihi A, Uppuluri P, Azie N, Edwards JE Jr, Ibrahim AS.

J Antimicrob Chemother. 2017 Feb;72(2):462-466. doi: 10.1093/jac/dkw433. Epub 2016 Oct 24.


Go Forth and Colonize: Dispersal from Clinically Important Microbial Biofilms.

Uppuluri P, Lopez-Ribot JL.

PLoS Pathog. 2016 Feb 18;12(2):e1005397. doi: 10.1371/journal.ppat.1005397. eCollection 2016 Feb. No abstract available.


Identification of Neuroradiology MRI Protocol Errors via a Quality-Driven Categorization Approach.

Ginat DT, Uppuluri P, Christoforidis G, Katzman G, Lee SK.

J Am Coll Radiol. 2016 May;13(5):545-8. doi: 10.1016/j.jacr.2015.08.027. Epub 2015 Oct 23. No abstract available.


In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms.

Sarkar S, Uppuluri P, Pierce CG, Lopez-Ribot JL.

Antimicrob Agents Chemother. 2014;58(2):1183-6. doi: 10.1128/AAC.01745-13. Epub 2013 Nov 11.


Antifungal therapy with an emphasis on biofilms.

Pierce CG, Srinivasan A, Uppuluri P, Ramasubramanian AK, López-Ribot JL.

Curr Opin Pharmacol. 2013 Oct;13(5):726-30. doi: 10.1016/j.coph.2013.08.008. Epub 2013 Sep 4. Review.


Expression of UME6, a key regulator of Candida albicans hyphal development, enhances biofilm formation via Hgc1- and Sun41-dependent mechanisms.

Banerjee M, Uppuluri P, Zhao XR, Carlisle PL, Vipulanandan G, Villar CC, López-Ribot JL, Kadosh D.

Eukaryot Cell. 2013 Feb;12(2):224-32. doi: 10.1128/EC.00163-12. Epub 2012 Dec 7.


Physiologic expression of the Candida albicans pescadillo homolog is required for virulence in a murine model of hematogenously disseminated candidiasis.

Uppuluri P, Chaturvedi AK, Jani N, Pukkila-Worley R, Monteagudo C, Mylonakis E, Köhler JR, Lopez Ribot JL.

Eukaryot Cell. 2012 Dec;11(12):1552-6. doi: 10.1128/EC.00171-12. Epub 2012 Oct 26.


Hsp90 governs dispersion and drug resistance of fungal biofilms.

Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, Lopez-Ribot JL, Andes D, Cowen LE.

PLoS Pathog. 2011 Sep;7(9):e1002257. doi: 10.1371/journal.ppat.1002257. Epub 2011 Sep 8.


Development of a high-throughput Candida albicans biofilm chip.

Srinivasan A, Uppuluri P, Lopez-Ribot J, Ramasubramanian AK.

PLoS One. 2011 Apr 22;6(4):e19036. doi: 10.1371/journal.pone.0019036.


Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion.

Uppuluri P, Srinivasan A, Ramasubramanian A, Lopez-Ribot JL.

Antimicrob Agents Chemother. 2011 Jul;55(7):3591-3. doi: 10.1128/AAC.01701-10. Epub 2011 Apr 25.


A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms.

Pierce CG, Uppuluri P, Tummala S, Lopez-Ribot JL.

J Vis Exp. 2010 Oct 21;(44). pii: 2287. doi: 10.3791/2287.


The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion.

Uppuluri P, Pierce CG, Thomas DP, Bubeck SS, Saville SP, Lopez-Ribot JL.

Eukaryot Cell. 2010 Oct;9(10):1531-7. doi: 10.1128/EC.00111-10. Epub 2010 Aug 13.


Dispersion as an important step in the Candida albicans biofilm developmental cycle.

Uppuluri P, Chaturvedi AK, Srinivasan A, Banerjee M, Ramasubramaniam AK, Köhler JR, Kadosh D, Lopez-Ribot JL.

PLoS Pathog. 2010 Mar 26;6(3):e1000828. doi: 10.1371/journal.ppat.1000828.


Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms.

Martins M, Uppuluri P, Thomas DP, Cleary IA, Henriques M, Lopez-Ribot JL, Oliveira R.

Mycopathologia. 2010 May;169(5):323-31. doi: 10.1007/s11046-009-9264-y. Epub 2009 Dec 13.


Candida albicans biofilm formation and its clinical consequences.

Uppuluri P, Pierce CG, López-Ribot JL.

Future Microbiol. 2009 Dec;4(10):1235-7. doi: 10.2217/fmb.09.85. No abstract available.


Characteristics of Candida albicans biofilms grown in a synthetic urine medium.

Uppuluri P, Dinakaran H, Thomas DP, Chaturvedi AK, Lopez-Ribot JL.

J Clin Microbiol. 2009 Dec;47(12):4078-83. doi: 10.1128/JCM.01377-09. Epub 2009 Sep 30.


Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis.

Lazzell AL, Chaturvedi AK, Pierce CG, Prasad D, Uppuluri P, Lopez-Ribot JL.

J Antimicrob Chemother. 2009 Sep;64(3):567-70. doi: 10.1093/jac/dkp242. Epub 2009 Jul 7.


Design of a simple model of Candida albicans biofilms formed under conditions of flow: development, architecture, and drug resistance.

Uppuluri P, Chaturvedi AK, Lopez-Ribot JL.

Mycopathologia. 2009 Sep;168(3):101-9. doi: 10.1007/s11046-009-9205-9. Epub 2009 Apr 16.


Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling.

Shapiro RS, Uppuluri P, Zaas AK, Collins C, Senn H, Perfect JR, Heitman J, Cowen LE.

Curr Biol. 2009 Apr 28;19(8):621-9. doi: 10.1016/j.cub.2009.03.017. Epub 2009 Mar 26.


Technical challenges in TIPS creation via the right subclavian vein.

Contractor SG, Merkulov A, Uppuluri PC, Bhatti W, Phatak T.

J Vasc Interv Radiol. 2008 Dec;19(12):1777-80. doi: 10.1016/j.jvir.2008.09.001. Epub 2008 Oct 31.


A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing.

Pierce CG, Uppuluri P, Tristan AR, Wormley FL Jr, Mowat E, Ramage G, Lopez-Ribot JL.

Nat Protoc. 2008;3(9):1494-500. doi: 10.1038/nport.2008.141.


Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms.

Uppuluri P, Nett J, Heitman J, Andes D.

Antimicrob Agents Chemother. 2008 Mar;52(3):1127-32. doi: 10.1128/AAC.01397-07. Epub 2008 Jan 7.


Candida albicans SNO1 and SNZ1 expressed in stationary-phase planktonic yeast cells and base of biofilm.

Uppuluri P, Sarmah B, Chaffin WL.

Microbiology. 2006 Jul;152(Pt 7):2031-8.


Supplemental Content

Loading ...
Support Center